JACI publishes results of PROTECT trial – breakthrough for cold sore sufferers

Spiralin® awarded as Active Ingredient of the Year 2015 in Aesthetic Dermatology

Scent optimisation of the skinicer® Repair Care product line

Development of a sales organisation in currently more than 20 export markets in collaboration with partner companies abroad 

Granting of a patent for the active extract from microalgae, Spiralin

Integration of Spiralin into the Oxyperm nail polish formulations

‘Product of the year 2014‘ award for the skinicer product line in the Journal of Aesthetic Dermatology

Introduction of the first Oxyperm nail polish: first oxygen-permeable cosmetic nail polish for damaged nails

Integration of Spiralin as new active extract from microalgae with extended therapeutic spectrum in all Spirularin and skinicer products

Product of the year 2013 award for the Spirularin product line in the Journal of Aesthetic Dermatology

Introduction of skinicer® Sedative Shampoo, Spirularin® Gel and Spirularin® Mousse with active microalgae protection. Introduction of the ocean pharma - products with partners in Ireland, Poland and Norway.

‘Company of the year 2012‘ award for ocean pharma in the Journal of Aesthetic Dermatology based on the unique active extract from microalgae, Spiralin, and the innovative product lines based on it 

Introduction of other products in the Spirularin® portfolio as well as Bone Conditioner tablets as dietary supplements for osteoporosis.

Introduction of the skinicer® Repair Care and Spirularin® VS product lines in Germany

Installation of the intrusion flow moulder for temperature-sensitive active ingredients in the in-house production

Introduction of hair & nails capsules

Establishment of a sales organisation in Turkey, in cooperation with Kammani Cosmetics/ Istanbul

Successful upscaling of the colloidal creatine Creamorph™ by means of the patented intrusion flow moulding method

Introduction of the topical Vet line based on microalgae, in cooperation with Riemser Arzneimittel AG

Start of the distribution in Switzerland in cooperation with Keller AG/ Burgdorf

Introduction of the CuraMar® product line with a first extract from microalgae

Introduction of mussel extract

to 2005: succession of generation - Patrick Günther and Jörg Keimes become new managing partners. Development and production of a first batch of a natural cholesterol reducing drug on the basis of Sitosterin for a start-up company

Acquisition of the intrusion moulding patent for creatine from BASF AG.

Use of Glucomanose, a pure natural ingredient of the Japanese Konjac plant, as an efficient weight reducing substance and successful launch of the brand “1-2-3 Schlank“.

Development of the “Winterizing“ method for the gentle separation of omega 3 fatty acids from undesirable fatty acids in cooperation with Norwegian fishermen and development of the first omega 3 products for the European market.

Introduction of “Muschel-Vit“.

Establishment of the company by Christian Günther. First introduction of the green-lipped mussel from New Zealand as natural product in Europe.